234 related articles for article (PubMed ID: 24419087)
1. Role of CHD5 in human cancers: 10 years later.
Kolla V; Zhuang T; Higashi M; Naraparaju K; Brodeur GM
Cancer Res; 2014 Feb; 74(3):652-8. PubMed ID: 24419087
[TBL] [Abstract][Full Text] [Related]
2. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.
Wu X; Zhu Z; Li W; Fu X; Su D; Fu L; Zhang Z; Luo A; Sun X; Fu L; Dong JT
Breast Cancer Res; 2012 May; 14(3):R73. PubMed ID: 22569290
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of CHD5 Inactivation in neuroblastomas.
Koyama H; Zhuang T; Light JE; Kolla V; Higashi M; McGrady PW; London WB; Brodeur GM
Clin Cancer Res; 2012 Mar; 18(6):1588-97. PubMed ID: 22294723
[TBL] [Abstract][Full Text] [Related]
4. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
[TBL] [Abstract][Full Text] [Related]
5. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
6. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
Thompson PM; Gotoh T; Kok M; White PS; Brodeur GM
Oncogene; 2003 Feb; 22(7):1002-11. PubMed ID: 12592387
[TBL] [Abstract][Full Text] [Related]
7. Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer.
Gorringe KL; Choong DY; Williams LH; Ramakrishna M; Sridhar A; Qiu W; Bearfoot JL; Campbell IG
Neoplasia; 2008 Nov; 10(11):1253-8. PubMed ID: 18953434
[TBL] [Abstract][Full Text] [Related]
8. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.
Quan J; Yusufzai T
J Biol Chem; 2014 Jul; 289(30):20717-26. PubMed ID: 24923445
[TBL] [Abstract][Full Text] [Related]
10. CHD5 is down-regulated through promoter hypermethylation in gastric cancer.
Wang X; Lau KK; So LK; Lam YW
J Biomed Sci; 2009 Oct; 16(1):95. PubMed ID: 19840376
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.
Cai C; Ashktorab H; Pang X; Zhao Y; Sha W; Liu Y; Gu X
PLoS One; 2012; 7(1):e29750. PubMed ID: 22235338
[TBL] [Abstract][Full Text] [Related]
12. Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancer.
Mulero-Navarro S; Esteller M
Epigenetics; 2008; 3(4):210-5. PubMed ID: 18698156
[TBL] [Abstract][Full Text] [Related]
13. The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.
Kolla V; Naraparaju K; Zhuang T; Higashi M; Kolla S; Blobel GA; Brodeur GM
Biochem J; 2015 Jun; 468(2):345-52. PubMed ID: 25825869
[TBL] [Abstract][Full Text] [Related]
14. The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.
Quan J; Adelmant G; Marto JA; Look AT; Yusufzai T
PLoS One; 2014; 9(9):e108066. PubMed ID: 25247294
[TBL] [Abstract][Full Text] [Related]
15. CHD5 is a potential tumor suppressor in non small cell lung cancer (NSCLC).
Baykara O; Tansarikaya M; Bulut P; Demirkaya A; Buyru N
Gene; 2017 Jun; 618():65-68. PubMed ID: 28400267
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
17. Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Garcia I; Mayol G; Rodríguez E; Suñol M; Gershon TR; Ríos J; Cheung NK; Kieran MW; George RE; Perez-Atayde AR; Casala C; Galván P; de Torres C; Mora J; Lavarino C
Mol Cancer; 2010 Oct; 9():277. PubMed ID: 20950435
[TBL] [Abstract][Full Text] [Related]
18. CHD5 is a tumor suppressor at human 1p36.
Bagchi A; Papazoglu C; Wu Y; Capurso D; Brodt M; Francis D; Bredel M; Vogel H; Mills AA
Cell; 2007 Feb; 128(3):459-75. PubMed ID: 17289567
[TBL] [Abstract][Full Text] [Related]
19. Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.
Naraparaju K; Kolla V; Zhuang T; Higashi M; Iyer R; Kolla S; Okawa ER; Blobel GA; Brodeur GM
Oncotarget; 2016 Mar; 7(13):15977-85. PubMed ID: 26895110
[TBL] [Abstract][Full Text] [Related]
20. Chd5 requires PHD-mediated histone 3 binding for tumor suppression.
Paul S; Kuo A; Schalch T; Vogel H; Joshua-Tor L; McCombie WR; Gozani O; Hammell M; Mills AA
Cell Rep; 2013 Jan; 3(1):92-102. PubMed ID: 23318260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
